Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2035-2041, May 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ennas, M.-G.
Right arrow Articles by Marschalek, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ennas, M.-G.
Right arrow Articles by Marschalek, R.

The Human ALL-1/MLL/HRX Antigen Is Predominantly Localized in the Nucleus of Resting and Proliferating Peripheral Blood Mononuclear Cells1

Maria-Grazia Ennas, Claudio Sorio, Ralf Greim, Mariella Nieddu, Aldo Scarpa, Simonetta Orlandini, Carlo M. Croce, Georg H. Fey and Rolf Marschalek2

Department of Cytomorphology [M-G. E.] and Institute of Biology [M. N.], Via Porcell 2, University of Cagliari, 09100 Cagliari, Italy; Department of Genetics, Staudtstrasse 5, University of Erlangen-Nürnberg, 91058 Erlangen, Germany [R. G., G. H. F., R. M.]; Institute of Surgical Pathology, Strada Le Grazie, University of Verona, 37134 Verona, Italy [C. S., A. S., S. O.]; and Kimmel Cancer Institute, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [C. M. C.]

The ALL-1 gene is an important regulator of embryonal and hematopoietic development, and structural variants of the human gene generated by chromosomal translocations and other genomic alterations presumably act as oncogenes in the pathogenesis of acute leukemias and other hematological malignancies. Antisera against two different epitopes of the human ALL-1 protein (anti-ALL1-N and anti-ALL1-C) were produced. Both sera revealed indistinguishable patterns of antigen localization in human peripheral blood mononuclear cells (PBMCs). In resting PBMCs, the antigen was distributed in a speckled pattern across the nuclei, with an increased density at the nuclear envelope and the nuclear indentation. In mitotically stimulated PBMCs, the antigen surrounded the condensing chromosomes but did not colocalize with chromatin or the nuclear scaffold. The antigen is considered a marker for a novel nuclear subcompartment, a perichromosomal area termed the "chromsomal envelope." In Western blot experiments, the anti-ALL1-N serum reacted with a polypeptide corresponding to the expected full-length 430-kDa ALL-1 protein. Recombinant proteins representing the AT-hook and zinc binding subdomains of the ALL-1 protein interacted in vitro with a degenerate mixture of double-stranded oligodeoxynucleotides. Thus, the ALL-1 protein probably is a DNA-binding protein with both a sequence-unspecific (AT-hook) and a sequence-specific (zinc binding subdomains) doublestranded DNA binding mode.

1 Supported by Research Grants SFB466-C4 (to R. M. and J. G.) and SFB466-C5 (to G. H. F. and R. M.) from the Deutsche Forschungsgemeinschaft; Research Grant Mar/93 from Johannes and Frieda Marohn Stiftung (to R. M. and J. G.); a research grant from the Associazione Italiana Ricerca Cancro to the Istituto Anatomia Patologica of Verona; and a seed grant from the Associazione Italiana Ricerca Cancro (to C. S.). R. M. was supported by a Career Development Award from the Ria Freifrau von Fritsch Stiftung. M-G. E., C. S., and R. G. contributed equally to this work.

2 To whom requests for reprints should be addressed, at Department of Genetics, University of Erlangen-Nürnberg, Staudtstrasse 5, D 91058 Erlangen, Germany. Phone: 49-9131-858530; Fax: 49-9131-858626; E-mail: rmarscha@biologie.uni-erlangen.de.

Received 1/22/97. Accepted 3/25/97.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
G. S. Stein
Mechanogenomic Control of DNA Exposure and Sequestration
Am. J. Pathol., April 1, 2005; 166(4): 959 - 962.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Zaidi, D. W. Young, J.-Y. Choi, J. Pratap, A. Javed, M. Montecino, J. L. Stein, J. B. Lian, A. J. van Wijnen, and G. S. Stein
Intranuclear Trafficking: Organization and Assembly of Regulatory Machinery for Combinatorial Biological Control
J. Biol. Chem., October 15, 2004; 279(42): 43363 - 43366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. K. Goto, T. Zor, M. Martinez-Yamout, H. J. Dyson, and P. E. Wright
Cooperativity in Transcription Factor Binding to the Coactivator CREB-binding Protein (CBP). THE MIXED LINEAGE LEUKEMIA PROTEIN (MLL) ACTIVATION DOMAIN BINDS TO AN ALLOSTERIC SITE ON THE KIX DOMAIN
J. Biol. Chem., November 1, 2002; 277(45): 43168 - 43174.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood, January 15, 2002; 99(2): 409 - 426.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. M. Pao, R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma
CBP/p300 interact with and function as transcriptional coactivators of BRCA1
PNAS, February 1, 2000; 97(3): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Yagi, K. Deguchi, A. Aono, Y. Tani, T. Kishimoto, and T. Komori
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Blood, July 1, 1998; 92(1): 108 - 117.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Caslini, A. Shilatifard, L. Yang, and J. L. Hess
The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation
PNAS, March 14, 2000; 97(6): 2797 - 2802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.